Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of COVID-19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid-regional pro-adrenomedullin.
Sozio E, Moore NA, Fabris M, Ripoli A, Rumbolo F, Minieri M, Boverio R, Rodríguez Mulero MD, Lainez-Martinez S, Martínez Martínez M, Calvo D, Gregoriano C, Williams R, Brazzi L, Terrinoni A, Callegari T, Hernández Olivo M, Esteban-Torrella P, Calcerrada I, Bernasconi L, Kidd SP, Sbrana F, Miguens I, Gordon K, Visentini D, Legramante JM, Bassi F, Cortes N, Montrucchio G, Di Lecce VN, Lauritano EC, García de Guadiana-Romualdo L, González Del Castillo J, Bernal-Morell E, Andaluz-Ojeda D, Schuetz P, Curcio F, Tascini C, Saeed K. Sozio E, et al. Among authors: visentini d. Respir Res. 2022 Aug 28;23(1):221. doi: 10.1186/s12931-022-02151-1. Respir Res. 2022. PMID: 36031619 Free PMC article.
Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab.
Fabris M, De Vita S, Blasone N, Visentini D, Pezzarini E, Pontarini E, Fabro C, Quartuccio L, Mazzolini S, Curcio F, Tonutti E. Fabris M, et al. Among authors: visentini d. Auto Immun Highlights. 2010 Nov 4;1(2):87-94. doi: 10.1007/s13317-010-0013-5. eCollection 2010 Nov. Auto Immun Highlights. 2010. PMID: 26000112 Free PMC article.
MR-proADM as prognostic factor of outcome in COVID-19 patients.
Sozio E, Tascini C, Fabris M, D'Aurizio F, De Carlo C, Graziano E, Bassi F, Sbrana F, Ripoli A, Pagotto A, Giacinta A, Gerussi V, Visentini D, De Stefanis P, Merelli M, Saeed K, Curcio F. Sozio E, et al. Among authors: visentini d. Sci Rep. 2021 Mar 4;11(1):5121. doi: 10.1038/s41598-021-84478-1. Sci Rep. 2021. PMID: 33664308 Free PMC article.
Extracellular vesicle features are associated with COVID-19 severity.
Caponnetto F, De Martino M, Stefanizzi D, Del Sal R, Manini I, Kharrat F, D'Aurizio F, Fabris M, Visentini D, Poz D, Sozio E, Tascini C, Cesselli D, Isola M, Beltrami AP, Curcio F. Caponnetto F, et al. Among authors: visentini d. J Cell Mol Med. 2023 Dec;27(24):4107-4117. doi: 10.1111/jcmm.17996. Epub 2023 Nov 15. J Cell Mol Med. 2023. PMID: 37964734 Free PMC article.
Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits.
Tonuttia E, Bassetti D, Piazza A, Visentini D, Poletto M, Bassetto F, Caciagli P, Villalta D, Tozzoli R, Bizzaro N. Tonuttia E, et al. Among authors: visentini d. Autoimmunity. 2004 Mar;37(2):171-6. doi: 10.1080/08916930310001657010. Autoimmunity. 2004. PMID: 15293886 Free article.
Interpretative comments on autoantibody tests.
Tonutti E, Visentini D, Bizzaro N. Tonutti E, et al. Among authors: visentini d. Autoimmun Rev. 2007 Jun;6(6):341-6. doi: 10.1016/j.autrev.2007.01.007. Epub 2007 Jan 29. Autoimmun Rev. 2007. PMID: 17537378 Review.
25 results